Reuters logo
BRIEF-Mast Therapeutics says updated timing for data from Vepoloxamer study
2016年6月6日 / 晚上9点27分 / 1 年前

BRIEF-Mast Therapeutics says updated timing for data from Vepoloxamer study

June 6 (Reuters) - Mast Therapeutics Inc :

* Updated anticipated timing for announcement of top-line data from phase 3 clinical study of Vepoloxamer in patients with sickle cell disease

* Delay does not reflect on quality or integrity of results or conduct of study Source text - 1.usa.gov/1rapPi2 Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below